BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25403182)

  • 1. miR-125b can enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival.
    Zhang L; Ge Y; Fuchs E
    Genes Dev; 2014 Nov; 28(22):2532-46. PubMed ID: 25403182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
    Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
    Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
    Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
    Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA.
    Bousquet M; Nguyen D; Chen C; Shields L; Lodish HF
    Haematologica; 2012 Nov; 97(11):1713-21. PubMed ID: 22689670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.
    Gastaldi C; Bertero T; Xu N; Bourget-Ponzio I; Lebrigand K; Fourre S; Popa A; Cardot-Leccia N; Meneguzzi G; Sonkoly E; Pivarcsi A; Mari B; Barbry P; Ponzio G; Rezzonico R
    Carcinogenesis; 2014 May; 35(5):1110-20. PubMed ID: 24374827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-125b/Lin28 pathway contributes to the mesendodermal fate decision of embryonic stem cells.
    Wang J; Cao N; Yuan M; Cui H; Tang Y; Qin L; Huang X; Shen N; Yang HT
    Stem Cells Dev; 2012 Jun; 21(9):1524-37. PubMed ID: 22277001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-365-targeted nuclear factor I/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma.
    Zhou L; Wang Y; Ou C; Lin Z; Wang J; Liu H; Zhou M; Ding Z
    Int J Biochem Cell Biol; 2015 Aug; 65():182-91. PubMed ID: 26072217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
    Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
    Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125b-2 overexpression represses ectodermal differentiation of mouse embryonic stem cells.
    Deng S; Zhang Y; Xu C; Ma D
    Int J Mol Med; 2015 Aug; 36(2):355-62. PubMed ID: 26059631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-125b regulates osteogenic differentiation of mesenchymal stem cells by targeting Cbfβ in vitro.
    Huang K; Fu J; Zhou W; Li W; Dong S; Yu S; Hu Z; Wang H; Xie Z
    Biochimie; 2014 Jul; 102():47-55. PubMed ID: 24560795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
    Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2.
    Xu N; Brodin P; Wei T; Meisgen F; Eidsmo L; Nagy N; Kemeny L; Ståhle M; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2011 Jul; 131(7):1521-9. PubMed ID: 21412257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients.
    Wang M; Zhu X; Sha Z; Li N; Li D; Chen L
    Br J Cancer; 2015 Mar; 112(5):874-82. PubMed ID: 25668010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
    Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
    Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
    Gong J; Zhang JP; Li B; Zeng C; You K; Chen MX; Yuan Y; Zhuang SM
    Oncogene; 2013 Jun; 32(25):3071-9. PubMed ID: 22824797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
    Yamane K; Jinnin M; Etoh T; Kobayashi Y; Shimozono N; Fukushima S; Masuguchi S; Maruo K; Inoue Y; Ishihara T; Aoi J; Oike Y; Ihn H
    J Mol Med (Berl); 2013 Jan; 91(1):69-81. PubMed ID: 22828925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.
    Darido C; Georgy SR; Wilanowski T; Dworkin S; Auden A; Zhao Q; Rank G; Srivastava S; Finlay MJ; Papenfuss AT; Pandolfi PP; Pearson RB; Jane SM
    Cancer Cell; 2011 Nov; 20(5):635-48. PubMed ID: 22094257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.